SINGLE-CELL ANALYSIS MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-09-13 |   Pages: 200+ |   Report ID: WR-2024-09-13-199034 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Single-cell Analysis Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL SINGLE-CELL ANALYSIS MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL SINGLE-CELL ANALYSIS MARKET

7.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA SINGLE-CELL ANALYSIS MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Becton, Dickinson and Company (US)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Danaher Corporation (US)

16.3 Merck Millipore (US)

16.4 QIAGEN (Netherlands)

16.5 Thermo Fisher Scientific (US)

16.6 General Electric Company (US)

16.7 10x Genomics (US)

16.8 Promega Corporation (US)

16.9 Illumina (US)

16.10 Bio-Rad Laboratories (US)

16.11 Fluidigm Corporation (US)

16.12 Agilent Technologies (US)

16.13 NanoString Technologies (US)

16.14 Tecan Group (Switzerland)

16.15 Sartorius AG (Germany)

16.16 Luminex Corporation (US)

16.17 Takara Bio (Japan)

16.18 Fluxion Biosciences (US)

16.19 Menarini Silicon Biosystems (Italy)

16.20 LumaCyte (US)

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Product
Consumables
 o Beads
 o Microplates
 o Reagents
 o Assay Kits
   o Immunoassays
   o Cell-based Assays
 o Other Consumables (Culture Dishes, Flasks, Tubes, Cuvettes, Cryovials, Filtration Apparatus, Petri Dishes, Inserts, and Discs)
Instruments
 o Flow Cytometers
 o NGS Systems
 o PCR Instruments
 o Spectrophotometers
 o Microscopes
 o Cell Counters
 o HCS Systems
 o Microarrays
 o Other Instruments (Laser Capture Microdissection (LCM) Systems, Micromanipulation Devices, and Integrated Fluidic Circuits (IFCs))

By Cell Type
Human Cells
Animal Cells
Microbial Cells

By Technique
Flow Cytometry
Next-generation Sequencing
Polymerase Chain Reaction
Microscopy
Mass Spectrometry
Other Techniques (Fluorescence In Situ Hybridization (FISH), Capillary Electrophoresis (CE), Single-Molecule Fluorescence In Situ Hybridization (smFISH), and Micromanipulation)

By Application
Research Applications
 o Cancer
 o Immunology
 o Neurology
 o Stem Cell
 o Other ResearchApplications (Tissue Regeneration, Drug Discovery, and Research on Aging)
Medical Applications
 o Noninvasive Prenatal Diagnosis
 o in Vitro Fertilization
 o Circulating Tumor Cell Detection

By End User
Academic & Research Laboratories
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostic Laboratories
Cell Banks & IVF Centers

Companies

Becton, Dickinson and Company (US)
Danaher Corporation (US)
Merck Millipore (US)
QIAGEN (Netherlands)
Thermo Fisher Scientific (US)
General Electric Company (US)
10x Genomics (US)
Promega Corporation (US)
Illumina (US)
Bio-Rad Laboratories (US)
Fluidigm Corporation (US)
Agilent Technologies (US)
NanoString Technologies (US)
Tecan Group (Switzerland)
Sartorius AG (Germany)
Luminex Corporation (US)
Takara Bio (Japan)
Fluxion Biosciences (US)
Menarini Silicon Biosystems (Italy)
LumaCyte (US)

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.